Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery

NCT03117855 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Company no longer interested in supporting this trial

Conditions

Bile Duct Adenocarcinoma
Stage III Intrahepatic Cholangiocarcinoma
Stage IVA Intrahepatic Cholangiocarcinoma
Stage IVB Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Capecitabine
OTHER: Laboratory Biomarker Analysis
RADIATION: Radioembolization

Sponsor

City of Hope Medical Center

Collaborators

[object Object]